Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26214 | 260 | 35.8 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
32 | 3 | OSTEOPOROSIS//VITAMIN D//OSTEOPOROSIS INTERNATIONAL | 107093 |
1401 | 2 | BISPHOSPHONATES//ZOLEDRONIC ACID//BONE METASTASES | 8069 |
26214 | 1 | BONE TARGETING//OSTEOTROPIC DRUG DELIVERY SYSTEM//ACIDIC OLIGOPEPTIDE | 260 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BONE TARGETING | authKW | 2842093 | 17% | 55% | 44 |
2 | OSTEOTROPIC DRUG DELIVERY SYSTEM | authKW | 822104 | 3% | 100% | 7 |
3 | ACIDIC OLIGOPEPTIDE | authKW | 375818 | 2% | 80% | 4 |
4 | MINERAL AFFINITY | authKW | 352330 | 1% | 100% | 3 |
5 | ASP OLIGOPEPTIDES | authKW | 234887 | 1% | 100% | 2 |
6 | DELIVERY TARGETING CONCEPT | authKW | 234887 | 1% | 100% | 2 |
7 | FEED QUAL INSPECT | address | 234887 | 1% | 100% | 2 |
8 | THERAPEUTIC AVAILABILITY | authKW | 234887 | 1% | 100% | 2 |
9 | HYDROXYAPATITE AFFINITY | authKW | 176162 | 1% | 50% | 3 |
10 | 1 PHOSPHONYL 1 THIAZOLYLETHYLENES | authKW | 117443 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Materials Science, Biomaterials | 591 | 8% | 0% | 21 |
2 | Pharmacology & Pharmacy | 528 | 28% | 0% | 72 |
3 | Chemistry, Organic | 348 | 18% | 0% | 46 |
4 | Chemistry, Medicinal | 306 | 11% | 0% | 28 |
5 | Chemistry, Multidisciplinary | 179 | 19% | 0% | 50 |
6 | Engineering, Biomedical | 114 | 6% | 0% | 15 |
7 | Oncology | 75 | 11% | 0% | 28 |
8 | Radiology, Nuclear Medicine & Medical Imaging | 73 | 8% | 0% | 20 |
9 | Endocrinology & Metabolism | 30 | 5% | 0% | 14 |
10 | Medicine, Research & Experimental | 22 | 5% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FEED QUAL INSPECT | 234887 | 1% | 100% | 2 |
2 | BIOENGN RADIOBIOL | 117443 | 0% | 100% | 1 |
3 | BIOMED ENGN HLTH TECSHENZHEN ADV TEC | 117443 | 0% | 100% | 1 |
4 | BIOMOLECULES MAX MOUSSERON | 117443 | 0% | 100% | 1 |
5 | CHILDRENS HOSP BOSTON ANESTHESIOL CRIT C | 117443 | 0% | 100% | 1 |
6 | CNRS UM1 UM2ENSCMUMR 5247 | 117443 | 0% | 100% | 1 |
7 | DRUG DELIVERY SYST EDUC MINIST | 117443 | 0% | 100% | 1 |
8 | FUNCT MAT MED DENT MED | 117443 | 0% | 100% | 1 |
9 | PREVENT ORAL HLTH | 117443 | 0% | 100% | 1 |
10 | TI RELEVANCE EXCELLENCE NEW DRUG DELIVER | 93952 | 1% | 40% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CONTROLLED RELEASE | 1899 | 4% | 0% | 11 |
2 | JOURNAL OF DRUG TARGETING | 1881 | 2% | 0% | 5 |
3 | BIOCONJUGATE CHEMISTRY | 1498 | 3% | 0% | 8 |
4 | DRUG DELIVERY | 1442 | 2% | 0% | 4 |
5 | LETTERS IN ORGANIC CHEMISTRY | 1074 | 2% | 0% | 4 |
6 | MOLECULAR PHARMACEUTICS | 925 | 2% | 0% | 5 |
7 | MACROMOLECULAR BIOSCIENCE | 925 | 2% | 0% | 4 |
8 | NUKLEARMEDIZINER | 792 | 0% | 1% | 1 |
9 | BIOMATERIALS SCIENCE | 775 | 1% | 0% | 2 |
10 | INVESTIGATIONAL NEW DRUGS | 730 | 2% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BONE TARGETING | 2842093 | 17% | 55% | 44 | Search BONE+TARGETING | Search BONE+TARGETING |
2 | OSTEOTROPIC DRUG DELIVERY SYSTEM | 822104 | 3% | 100% | 7 | Search OSTEOTROPIC+DRUG+DELIVERY+SYSTEM | Search OSTEOTROPIC+DRUG+DELIVERY+SYSTEM |
3 | ACIDIC OLIGOPEPTIDE | 375818 | 2% | 80% | 4 | Search ACIDIC+OLIGOPEPTIDE | Search ACIDIC+OLIGOPEPTIDE |
4 | MINERAL AFFINITY | 352330 | 1% | 100% | 3 | Search MINERAL+AFFINITY | Search MINERAL+AFFINITY |
5 | ASP OLIGOPEPTIDES | 234887 | 1% | 100% | 2 | Search ASP+OLIGOPEPTIDES | Search ASP+OLIGOPEPTIDES |
6 | DELIVERY TARGETING CONCEPT | 234887 | 1% | 100% | 2 | Search DELIVERY+TARGETING+CONCEPT | Search DELIVERY+TARGETING+CONCEPT |
7 | THERAPEUTIC AVAILABILITY | 234887 | 1% | 100% | 2 | Search THERAPEUTIC+AVAILABILITY | Search THERAPEUTIC+AVAILABILITY |
8 | HYDROXYAPATITE AFFINITY | 176162 | 1% | 50% | 3 | Search HYDROXYAPATITE+AFFINITY | Search HYDROXYAPATITE+AFFINITY |
9 | 1 PHOSPHONYL 1 THIAZOLYLETHYLENES | 117443 | 0% | 100% | 1 | Search 1+PHOSPHONYL+1+THIAZOLYLETHYLENES | Search 1+PHOSPHONYL+1+THIAZOLYLETHYLENES |
10 | 2 PHOSPHONO PYRIDINES | 117443 | 0% | 100% | 1 | Search 2+PHOSPHONO+PYRIDINES | Search 2+PHOSPHONO+PYRIDINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | COLE, LE , VARGO-GOGOLA, T , ROEDER, RK , (2016) TARGETED DELIVERY TO BONE AND MINERAL DEPOSITS USING BISPHOSPHONATE LIGANDS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 99. ISSUE . P. 12 -27 | 48 | 28% | 3 |
2 | ZHAO, Y , HE, DS , MA, LF , GUO, L , (2015) SYNTHESIS AND PRELIMINARY EVALUATION OF NOVEL BONE-TARGETING NSAIDS PRODRUGS BASED ON GLUTAMIC ACID OLIGOPEPTIDES.LETTERS IN DRUG DESIGN & DISCOVERY. VOL. 12. ISSUE 7. P. 585 -590 | 16 | 73% | 0 |
3 | OSSIPOV, DA , (2015) BISPHOSPHONATE-MODIFIED BIOMATERIALS FOR DRUG DELIVERY AND BONE TISSUE ENGINEERING.EXPERT OPINION ON DRUG DELIVERY. VOL. 12. ISSUE 9. P. 1443 -1458 | 27 | 39% | 4 |
4 | ULUDAG, H , (2002) BISPHOSPHONATES AS A FOUNDATION OF DRUG DELIVERY TO BONE.CURRENT PHARMACEUTICAL DESIGN. VOL. 8. ISSUE 21. P. 1929-1944 | 29 | 37% | 75 |
5 | OUYANG, L , HE, DS , ZHANG, J , HE, G , JIANG, B , WANG, Q , CHEN, ZJ , PAN, JZ , LI, YH , GUO, L , (2011) SELECTIVE BONE TARGETING 5-FLUOROURACIL PRODRUGS: SYNTHESIS AND PRELIMINARY BIOLOGICAL EVALUATION.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 19. ISSUE 12. P. 3750 -3756 | 15 | 56% | 10 |
6 | NEALE, JR , RICHTER, NB , MERTEN, KE , TAYLOR, KG , SINGH, S , WAITE, LC , EMERY, NK , SMITH, NB , CAI, J , PIERCE, WM , (2009) BONE SELECTIVE EFFECT OF AN ESTRADIOL CONJUGATE WITH A NOVEL TETRACYCLINE-DERIVED BONE-TARGETING AGENT.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 19. ISSUE 3. P. 680-683 | 11 | 79% | 14 |
7 | HIRABAYASHI, H , FUJISAKI, J , (2003) BONE-SPECIFIC DRUG DELIVERY SYSTEMS - APPROACHES VIA CHEMICAL MODIFICATION OF BONE-SEEKING AGENTS.CLINICAL PHARMACOKINETICS. VOL. 42. ISSUE 15. P. 1319-1330 | 22 | 42% | 65 |
8 | IONESCU, C , RIZEA, SC , BARRAGAN-MONTERO, V , NEAMTU, J , (2013) SYNTHESIS AND CHARACTERIZATION OF A CARBOXYLIC ACID DERIVATIVE FOR LIPOSOMAL PREPARATIONS.FARMACIA. VOL. 61. ISSUE 4. P. 725-735 | 9 | 69% | 0 |
9 | YEWLE, JN , PULEO, DA , BACHAS, LG , (2013) BIFUNCTIONAL BISPHOSPHONATES FOR DELIVERING PTH (1-34) TO BONE MINERAL WITH ENHANCED BIOACTIVITY.BIOMATERIALS. VOL. 34. ISSUE 12. P. 3141-3149 | 17 | 35% | 6 |
10 | WANG, GL , MOSTAFA, NZ , INCANI, V , KUCHARSKI, C , ULUDAG, H , (2012) BISPHOSPHONATE-DECORATED LIPID NANOPARTICLES DESIGNED AS DRUG CARRIERS FOR BONE DISEASES.JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A. VOL. 100A. ISSUE 3. P. 684 -693 | 13 | 41% | 20 |
Classes with closest relation at Level 1 |